bortezomib with refractory multiple myeloma who have received lenalidomide and Phase 1 study of pomalidomide MTD, safety, and efficacy in patients
Year: 2013
Type: article
Authors: Min Chen, M. Zaki, Christian Jacques, Laura McBride, Elizabeth Bilotti, Palka Anand, Lisa Nardelli, Gail Larkins, Daniel M. Sullivan, Melissa Alsina, Robert Schlossman, Irene M. Ghobrial, Deborah Doss, Paul G. Richardson, David S. Siegel, Rachid Baz, Susan L. Kelley, Nikhil C. Munshi, Jacob P. Laubach
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2339208702